Trends in Opioid Prescribing by Oncologists for Medicare Beneficiaries from 2014 to 2022
Link
            
        Description
        Examines trends in opioid prescribing among oncologists before and after the FDA's 2018 Risk Evaluation and Mitigation Strategy for opioids revision, utilizing 2014-2022 Medicare Part D Prescriber Public Use Files data. Breaks down data by opioid type, oncologist subspecialty, geographic region, and rurality.
    Author(s)
            Shaimaa Elshafie, Lorenzo Villa Zapata
        Citation
            Journal of Managed Care & Specialty Pharmacy, 31(10), 991-996
        Date
            10/2025
        Tagged as
                                    Cancer
                 ·                          Pharmacy and prescription drugs
                 ·                          Policy
                 ·                          Rural-urban differences
                 ·                          Statistics and data
                     
        